The firm has been hurt and continues to be hurt by the effects of the pandemic.
Charts are looking 'toppy' right now.
Let's check the charts and indicators.
The technical signals of the diversified health care company still don't inspire confidence to establish long positions in its stock at this time.
A closer look at the fund's composition leads to a few head-scratchers, but most of the names seem to fairly represent its focus.
As several parts of the world struggle with Covid-19 surges, MRNA could win in the long war against the pandemic.
ARK Innovation ETF offered a glimmer of technical hope Thursday to those following the high-growth space, plus we look at two new stocks.
Here's what it's going to take to turn the charts positive.
Here's what the charts show for BHC as the name prepares to post earnings on Wednesday.
Here's what trades should do.